Adenosine receptor antagonists inhibit the development of morphine sensitization in the C57BL/6 mouse

Neuroscience Letters

Volumn 264, Issue 1-3, 1999, Pages 89-92

  Weisberg, Stuart P ^a,b   Kaplan, Gary B ^a,b  

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Adenosine; Caffeine; Morphine; Opiates; Purinergic; Receptor; Substance dependence syndrome

Indexed keywords

8 (2 AMINO 4 CHLOROPHENYL) 1,3 DIPROPYLXANTHINE; ADENOSINE RECEPTOR BLOCKING AGENT; MORPHINE;

ANIMAL EXPERIMENT; ARTICLE; DOPAMINERGIC SYSTEM; LIMBIC CORTEX; MOBILIZATION; MORPHINE ADDICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

ADENOSINE; ANIMALS; CAFFEINE; DRUG COMBINATIONS; DRUG RESISTANCE; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; MORPHINE; MOTOR ACTIVITY; NARCOTICS; RECEPTORS, PURINERGIC P1; XANTHINES;

EID: 0033515785     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00188-3     Document Type: Article

References (18)

1. Bonci A., Williams J.T. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron. 16:1996;631-639.
2. Dethy S., Laute M.A., Togasaki D.M., Przedborski S., Damhaut P., Thiry P., Hildebrand J., Goldman S. Systemic and intrastriatal theophylline have opposite effects on dopamine and dopamine metabolites measured by intrastriatal microdialysis in the rat. Neurosci. Lett. 208:1996;159-162.
3. Florio C., Rosati A.M., Traversa U., Vertua R. Inhibitory and excitatory effects of adenosine antagonists on spontaneous locomotor activity in mice. Life Sci. 60:1997;1477-1486.
4. Glass M., Faull R.L.M., Dragunow M. Localisation of the adenosine uptake site in the human brain: a comparison with the distribution of adenosine A1 receptors. Brain Res. 710:1996;79-91.
5. Kalivas P.W., Duffy P. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons. J. Pharmacol. Exp. Ther. 241:1987;204-212.
6. Kaplan G.B., Tai N.T., Greenblatt D.J., Shader R.I. Caffeine-induced behavioral stimulation is dose- and concentration-dependent. Br. J. Pharmacol. 100:1990;435-440.
7. Kaplan G.B., Coyle T.S. Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation. Eur. J. Pharmacol. 362:1998;1-8.
8. Klitenick M.A., DeWitte P., Kalivas P.W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J. Neurosci. 12:1992;2623-2632.
9. Kuribara H., Tadokoro S. Reverse tolerance to ambulation-increasing effects of methamphetamine and morphine in six mouse strains. Jpn. J. Pharmacol. 49:1989;197-203.
10. Kuribara H. Caffeine enhances acute stimulant effect of morphine but inhibits morphine sensitization when assessed by ambulation in mice. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 19:1995;313-321.
11. Latimer L.G., Duffy P., Kalivas P.W. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J. Pharmacol. Exp. Ther. 241:1987;328-337.
12. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology. 98:1989;357-362.
13. Mahan L.C., McVittie L.D., Smyk-Randall E.M., Nakata H., Monsma F.J., Gerfen C.R., Sibley D.R. Cloning and expression of an A1 Adenosine Receptor from Rat Brain. Mol. Pharmacol. 40:1991;1-7.
14. Murai T., Koshikawa N., Kanayama T., Takada K., Tomiyama K., Kobayashi M. Opposite effects of midazolam and β-carboline-3-carboxylate ethyl ester on the release of dopamine from rat nucleus accumbens measured by in vivo microdialysis. Eur. J. Pharmacol. 261:1994;65-71.
15. Stoner G.R., Skirboll L.R., Werkman S., Hommer D.W. Preferential effects of caffeine on limbic and cortical dopamine systems. Biol. Psychiatry. 23:1988;761-768.
16. Vezina P., Kalivas P.W., Stewart J. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res. 417:1987;51-58.
17. Williams M. Adenosine antagonists, Medicinal Res. Rev. 9:1989;219-243.
18. B-medicated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons. J. Pharmacol. Exp. Ther. 273:1995;575-581.